BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22670601)

  • 1. Mini-review: spinocerebellar ataxias: an update of SCA genes.
    Trott A; Houenou LJ
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):115-21. PubMed ID: 22670601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
    Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
    Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of Spinocerebellar ataxias in Koreans: frequencies and reference ranges of SCA1, SCA2, SCA3, SCA6, and SCA7.
    Kim JY; Park SS; Joo SI; Kim JM; Jeon BS
    Mol Cells; 2001 Dec; 12(3):336-41. PubMed ID: 11804332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spinocerebellar ataxias: order emerges from chaos.
    Margolis RL
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):447-56. PubMed ID: 12169226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The occurrence of spinocerebellar ataxias caused by dynamic mutations in Polish patients.
    Sułek-Piatkowska A; Zdzienicka E; Raczyńska-Rakowicz M; Krysa W; Rajkiewicz M; Szirkowiec W; Zaremba J
    Neurol Neurochir Pol; 2010; 44(3):238-45. PubMed ID: 20625959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell biology of spinocerebellar ataxia.
    Orr HT
    J Cell Biol; 2012 Apr; 197(2):167-77. PubMed ID: 22508507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical diagnosis of autosomal dominant spinocerebellar ataxias.
    Klockgether T
    Cerebellum; 2008; 7(2):101-5. PubMed ID: 18418679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.
    Zoghbi HY; Orr HT
    J Biol Chem; 2009 Mar; 284(12):7425-9. PubMed ID: 18957430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients.
    Maruyama H; Izumi Y; Morino H; Oda M; Toji H; Nakamura S; Kawakami H
    Am J Med Genet; 2002 Jul; 114(5):578-83. PubMed ID: 12116198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting several CAG expansion diseases by a single antisense oligonucleotide.
    Evers MM; Pepers BA; van Deutekom JC; Mulders SA; den Dunnen JT; Aartsma-Rus A; van Ommen GJ; van Roon-Mom WM
    PLoS One; 2011; 6(9):e24308. PubMed ID: 21909428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of spinocerebellar ataxia type 1 disease.
    Kang S; Hong S
    Mol Cells; 2009 Jun; 27(6):621-7. PubMed ID: 19572115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration: a question of balance.
    Thompson LM
    Nature; 2008 Apr; 452(7188):707-8. PubMed ID: 18401401
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward cell specificity in SCA1.
    Humbert S; Saudou F
    Neuron; 2002 May; 34(5):669-70. PubMed ID: 12062012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial tRNALeu/Lys and ATPase 6/8 gene variations in spinocerebellar ataxias.
    Safaei S; Houshmand M; Banoei MM; Panahi MS; Nafisi S; Parivar K; Rostami M; Shariati P
    Neurodegener Dis; 2009; 6(1-2):16-22. PubMed ID: 19066432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal-dominant cerebellar ataxias.
    Mundwiler A; Shakkottai VG
    Handb Clin Neurol; 2018; 147():173-185. PubMed ID: 29325610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
    Buijsen RAM; Toonen LJA; Gardiner SL; van Roon-Mom WMC
    Neurotherapeutics; 2019 Apr; 16(2):263-286. PubMed ID: 30607747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group.
    Pujana MA; Corral J; Gratacòs M; Combarros O; Berciano J; Genís D; Banchs I; Estivill X; Volpini V
    Hum Genet; 1999 Jun; 104(6):516-22. PubMed ID: 10453742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.
    Hong S; Kim SJ; Ka S; Choi I; Kang S
    Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.
    Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EM; Orr HT; Botas J; Zoghbi HY
    Cell; 2003 May; 113(4):457-68. PubMed ID: 12757707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.